A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II)
- Author(s)
- Rossi, AJ; Verbus, EA; Faries, MB; Moncrieff, M; Henderson, M; Hernandez, JM; Lowe, MC;
- Details
- Publication Year 2022-07,Volume 29,Issue #7,Page 4050-4051
- Journal Title
- Annals of Surgical Oncology
- Publication Type
- Commentary
- Department(s)
- Surgical Oncology
- PubMed ID
- 35451728
- Publisher's Version
- https://doi.org/10.1245/s10434-022-11766-z
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-03-07 05:57:24
Last Modified: 2025-03-07 06:00:21